<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE rss [<!ENTITY % HTMLlat1 PUBLIC "-//W3C//ENTITIES Latin 1 for XHTML//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml-lat1.ent">]>
<rss version="2.0" xml:base="http://www.caltechcancer.org">
<channel>
 <title>NSBCC: NanoSystems Biology Cancer Center - Project 4</title>
 <link>http://www.caltechcancer.org/taxonomy/term/88/0</link>
 <description>Nanotechnologies for Quantitating Pi3-Kinase Pathway Biomarkers in Mice and Humans Treated with Biomarkers</description>
 <language>en</language>
<item>
 <title>Cross-species comparisons of cancer signaling.  Nat Genet.  2005 37:7-8  (Graeber &amp; Sawyers)</title>
 <link>http://www.caltechcancer.org/node/207</link>
 <description>&lt;span class=&quot;articletext&quot;&gt;&lt;b&gt;Modeling of human cancer in genetically engineered mice and genome-wide measurements of mRNA expression have now been combined to accelerate the search for new molecularly targeted therapies against cancer. Looking forward, we propose a community-wide systematic effort to model and characterize an array of different cancer-related aberrant signaling pathways in several mouse models of cancer.&lt;/b&gt;&lt;/span&gt; &lt;table cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; width=&quot;450&quot; border=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td style=&quot;height: 20px&quot;&gt;&lt;img height=&quot;20&quot; src=&quot;images/spacer.gif&quot; width=&quot;1&quot; /&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/t</description>
 <category domain="http://www.caltechcancer.org/nsbccpublications">NSBCC Publications</category>
 <category domain="http://www.caltechcancer.org/project4">Project 4</category>
 <pubDate>Tue, 28 Feb 2006 10:32:07 -0800</pubDate>
</item>
</channel>
</rss>
